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Increased generation of reactive oxygen species (ROS) is implicated in “glucose toxicity” in diabetes. However, little is known about the action
of glucose on the expression of transcription factors in hepatocytes, especially those involved in mitochondrial DNA (mtDNA) replication and
transcription. Since mitochondrial functional capacity is dynamically regulated, we hypothesized that stressful conditions of hyperglycemia induce
adaptations in the transcriptional control of cellular energy metabolism, including inhibition of mitochondrial biogenesis and oxidative metabolism.
Cell viability, mitochondrial respiration, ROS generation and oxidized proteins were determined in HepG2 cells cultured in the presence of either
5.5 mM (control) or 30 mM glucose (high glucose) for 48 h, 96 h and 7 days. Additionally, mtDNA abundance, plasminogen activator inhibitor-1
(PAI-1), mitochondrial transcription factor A (TFAM) and nuclear respiratory factor-1 (NRF-1) transcripts were evaluated by real time PCR. High
glucose induced a progressive increase in ROS generation and accumulation of oxidized proteins, with no changes in cell viability. Increased
expression of PAI-1 was observed as early as 96 h of exposure to high glucose. After 7 days in hyperglycemia, HepG2 cells exhibited inhibited
uncoupled respiration and decreased MitoTracker Red fluorescence associated with a 25% decrease in mtDNA and 16% decrease in TFAM
transcripts. These results indicate that glucose may regulate mtDNA copy number by modulating the transcriptional activity of TFAM in response to
hyperglycemia-induced ROS production. The decrease of mtDNA content and inhibition of mitochondrial function may be pathogenic hallmarks in
the altered metabolic status associated with diabetes.
© 2007 Elsevier Inc. All rights reserved.Keywords: Hyperglycemia; Mitochondrial biogenesis; Oxidative stress; BioenergeticsIntroduction
Diabetes mellitus is a metabolic disorder characterized by
hyperglycemia and insufficiency of secretion or receptor
insensitivity to endogenous insulin. The number of adults with
clinical diagnosis of diabetes has been increasing dramatically
worldwide. It has been estimated that the number of adults
affected by diabetes in the world will grow from 135 million in
1995 to 300 million in the year 2025 (King et al., 1998). While
exogenous insulin and other medications can control many
aspects of diabetes, assorted complications affecting the⁎ Corresponding author. Fax: +351 239 855789.
E-mail address: palmeira@ci.uc.pt (C.M. Palmeira).
0041-008X/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.taap.2007.07.015vascular system, kidney, and peripheral nerves are common
and extremely costly in terms of longevity and quality of life.
It is well established that hyperglycemia elicits an increase in
reactive oxygen species (ROS) production, due to increased
input of reducing equivalents into the mitochondrial electron
transport chain (Nishikawa et al., 2000a; Brownlee, 2001). ROS
overproduction is the trigger of the pathways responsible for
hyperglycemia-induced cell damage: (1) increased polyol
pathway flux; (2) increased advanced glycation end product
(AGE) formation; (3) activation of protein kinase C (PKC)
isoforms; and (4) increased hexosamine pathway flux (Nishi-
kawa et al., 2000b; Brownlee, 2001; Robertson, 2004).
Diabetes-associated alterations in mitochondrial phenotype
have been widely described (Rolo and Palmeira, 2006). In
animal models of diabetes, distinct mitochondrial alterations as a
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adaptation mechanisms to counteract high glucose levels
(Palmeira et al., 1999; Ferreira et al., 1999, 2003). Since
mitochondrial number and function require both nuclear and
mitochondrial-encoded genes, coordinated mechanisms exist to
regulate the two genomes and determine the overall oxidative
capacity (Kelly and Scarpulla, 2004). Adaptive responses of
mitochondrial function to diabetic stress may reflect changes in
mitochondrial gene expression induced by hyperglycemia.
Growing evidence indicates that several transcriptional changes
in diabetes are associated with impaired mitochondrial function
and altered glucose and fatty acid metabolism, characteristics
of diabetes mellitus. Reduced expression of oxidative phos-
phorylation genes has been observed in type 2 diabetes
(Mootha et al., 2003), accompanied by decreased expression
of peroxisomal proliferators activator receptor γ coactivator-α
(PGC-1α) in prediabetic and diabetic muscle (Patti et al.,
2003). PGC-1α is an integrator of the molecular regulatory
circuit involved in the transcriptional control of cellular energy
metabolism, including mitochondrial biogenesis, hepatic glu-
coneogenesis, and fatty acid β-oxidation (Puigserver and
Spiegelman, 2003). Recent work by Yu and collaborators has
shown that exposure to high glucose conditions leads to
dynamic changes in mitochondrial morphology due to
prolonged ROS overproduction (Yu et al., 2006). However,
the relationship between ROS production and mitochondrial
biogenesis is still unclear.
Based on the indication of modulation of gene expression
and alteration of mitochondrial function by hyperglycemia, we
hypothesize that hyperglycemia-induced increased ROS pro-
duction is the trigger for decreased mitochondrial biogenesis.
We demonstrated that prolonged hyperglycemia-induced ROS
overproduction causes a decrease in mitochondrial copy num-
ber in HepG2 cells. We also found that this decrease in mito-
chondrial biogenesis is coincident to a decrease in TFAM
transcripts and results in a loss of respiratory efficiency. Liver
being the primary organ involved in blood glucose metabolism,
decreased mitochondrial biogenesis and subsequent impairment
of oxidative metabolism will establish a vicious cycle of met-
abolic alterations implicated in diabetes pathogenesis.
Materials and methods
Cell culture. HepG2/C3A cells obtained from American Type Culture Col-
lection (ATCC, Rockville, MD) were cultured in Eagle's minimum essential
medium (MEM) (with 2 mM L-glutamine and Earl's BSS adjusted to contain
1.5 g/l sodium bicarbonate, 0.1 mM nonessential amino acids, and 1 mM sodium
pyruvate (Sigma, St. Louis, MO)), supplemented with 10% fetal bovine serum.
Cells were plated on 25- or 75-cm2 tissue culture flasks and grown in a 5% CO2
incubator at 37 °C with saturating humidity and growth media changes every
2 days. At 80–90% confluence, cells were passaged by detachment with 0.05%
trypsin and 0.5 mM EDTA (Invitrogen, Carlsbad, CA) and re-seeded into new
flasks. Harvesting of cells was accomplished by trypsinization or by removing
the media and scraping in a small volume of assay dependent specific buffer. For
hyperglycemic exposure of the cells for 48 h, 96 h or 7 days, culture media was
supplemented with 30 mM glucose.
Cell viability. Viability or cell killing was evaluated by using the fluorescent
markers Ethidium homodimer-1 (EtHD-1) and calcein-AM (Molecular Probes,
Eugene, OR). EtHD-1 is excluded from cells with intact membranes butreadily enters dead cells and intercalates DNA, thereby producing a bright red
fluorescence in dead cells (ex/em ∼495 nm/∼635 nm). C-AM freely diffuses
into cells and is cleaved by intracellular esterases to the fluorescent isoform,
which is polarized and trapped in the cell, producing a bright green
fluorescence in live cells (ex/em ∼495 nm/∼515 nm). Cells were harvested
by trypsinization and washed twice with PBS. Cells were resuspended in the
working solution of calcein-AM (2 μM) and EtHD-1 (4 μM) and incubated
for 30 min at 37 °C. The cells were then analyzed with a FACSCalibur flow
cytometer (Becton Dickinson, San Jose, CA, US) and CELLQuest software.
Approximately 105 cells were analyzed for each time point and condition.
Viability or cell killing is calculated as a ratio of EtHD-1 and calcein-AM
events (Rolo et al., 2004).
In cyto mitochondrial ROS generation. ROS were determined fluorome-
trically using a Labsystems type 374 plate-reader fluorometer. The formation
of the oxidized derivative of 5-(and 6-)-chloromethyl-2′,7′-dichlorodihydro-
fluorescein (CM-H2DCF) was monitored fluorometrically at an excitation
wavelength 485 nm and an emission wavelength 538 nm (Zhou et al., 2001).
Briefly, cells were collected by trypsinization and centrifugation, and
resuspended at 1×106 cells per ml in culture media. Cells were loaded with
50 μM CM-H2DCFDA (Molecular Probes), prepared in DMSO, for 15 min at
37 °C and 200 μl of the cell suspension (105 cells) were loaded into a 96-well
plate. The fluorescence was monitored for 30 min to calculate the rate of ROS
formation.
Oxidized proteins detection. Protein carbonyl groups were immunodetected
with OxyBlot Protein Oxidation Detection Kit (Chemicon International,
Temecula, CA), according to manufacturer's suggestions. Briefly, cells were
collected by trypsinization and centrifugation, resuspended in 200 μl of ice-cold
PBS and homogenized by syringe and needle. 20 μg of protein were denatured
with an equal volume of SDS (final concentration of 6% SDS) and derivatized
with 2 volumes of 2,4-dinitrophenylhydrazine (DNPH) solution. After
incubation at room temperature for 15 min, the reaction was stopped by
addition of the neutralization solution. The derivatized protein samples were
separated by standard SDS PAGE using precast gels. Proteins were then
transferred to a nitrocellulose membrane for 90 min at 100 V in transfer buffer
(25 mM Tris, 190 mM glycine, 20% methanol) containing 0.01% SDS. The
loading and transfer of equal amounts of protein was confirmed by staining the
nitrocellulose membrane with Ponceau S (data not shown). Non-specific sites on
the membrane were blocked in a 1% casein solution of Tris-buffered saline with
0.1% Tween 20. Membranes were blotted with rabbit anti-DNP (1:150, 90451
from Chemicon International, CA). A horseradish peroxidase-conjugated
secondary antibody (goat anti-rabbit 90452, 1:300, Chemicon International,
CA) was used for the detection of immunoblotted proteins according to
manufacturer's recommendations (Pierce, IL). Chemiluminescence was
detected on film.
Measurement of protein carbonyl by spectrophotometry. Protein carbonyl
content was measured by using 2,4-dinitrophenyl-hydrazine (DNPH) (Levine
et al., 1994). Cells were collected by trypsinization and centrifugation,
resuspended in 200 μl of ice-cold PBS and homogenized by syringe and needle.
500 μl ice-cold trichloroacetic acid (20% w/v) were added to 250 μg of sample
and allowed to stand for 15min at 4 °C. The precipitated protein was collected by
centrifugation at 6500×g for 10 min, and the supernatant was discarded. The
pellet was fully resuspended in 500 μl of 0.1 M NaOH. 500 μl of 10 mM DNPH
dissolved in 2 M HCl was added to the sample tube. In a parallel, a blank was
prepared by addition of 500 μl of 2 M HCl containing no DNPH to the protein
sample. After incubation at room temperature, in the dark, for 30 min 500 μl of
trichloroacetic acid (20% w/v) were added. The precipitated protein was
collected by centrifugation at 6500×g for 10 min, and the supernatant was
discarded. The pellet was washed three times with 1 ml of a 1:1 (v/v) mixture of
ethanol and ethyl acetate and centrifuged at 6500×g for 5 min to remove free
reagent. The final precipitated protein was redissolved in 200 μl of 6M guanidine
hydrochloride solution. The amount of protein dinitrophenylhydrozone
derivative was quantified by measuring the absorbance at 365 nm and converted
to nmol of hydrazone by using a molar absorption coefficient of
22,000 M−1 cm−1. Carbonyl content was expressed as nmol of DNPH
incorporated per milligram of protein.
Fig. 2. Exposure of HepG2 cells to hyperglycemia (30mM) induce an increase in
ROS formation. Cells were cultured in 5.5 mM or 30 mM glucose for 48 h, 96 h
and 7 days. ROS were estimated fluorometrically using the probe CM-
H2DCFDA, and are expressed as fluorescent intensity increase per 105 cells per
10 min. Bars represent the mean±S.E.M. for three different cell cultures. All the
bars at 30 mM glucose are statistically different when compared with the cor-
responding normoglycemic (5.5 mM) control group ( pb0.05).
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sumption rates were measured in permeabilized cells using a Clark-type O2
electrode. Cells were collected by trypsinization and centrifugation, and
resuspended at 5×106 cells per ml in 1 ml of buffer A (250 mM sucrose,
10 mM MgCl2, 20 mM HEPES (pH 7.1)). 1 ml of buffer A containing 50 μg
digitonin was then added to the cell suspension. The suspension was placed
in a water bath at 37 °C with agitation for 3 min and then diluted with 8 ml
of buffer A. Cells were then collected by centrifugation and resuspended in
700 μl of respiration buffer (250 mM sucrose, 10 mM MgCl2, 2 mM
KH2PO4, 20 mM HEPES (pH 7.1)). Each sample was transferred into a
water-jacketed chamber containing a magnetic bar and connected to a
circulating water bath at 28 °C and a YS model 5300 biological oxygen
monitor (Yellow Springs Instruments). After equilibration of the cell
suspension, 10 mM glutamate/malate were added to the chamber, following
an additional equilibration ADP 1 mM was added. Uncoupled respiration was
evaluated in cells resuspended in respiration media supplemented with
glutamate/malate by adding DNP 10 μM to stimulate oxygen consumption;
after allowing adequate time for accurate slope measurement, 2 mM KCN
was added (Hofhaus et al., 1996).
Fluorescence microscopy of cultured cells. Cells were collected by trypsini-
zation and centrifugation, washed with PBS, seeded at approximately 30%
confluence in 6-well plates on glass cover slips, incubated overnight and then
stained with Mitotracker Red (Molecular Probes) for 15 min. Cells were then
rinsed with PBS and fresh media was added. Cells were visualized using a Nikon
Eclipse TE300 inverted epifluorescence microscope.
Quantitative real-time PCR for measurement of mtDNA copies/cell. DNA
was extracted using phenol/chloroform precipitation methods and stored in
water at −80 °C until analysis (Strauss, 1998). Purity and concentration of
DNA recovered were determined with a NanoDrop spectrophotometer. To
assess mtDNA content per cell, we measured the number of copies of well-
conserved single-copy genes (Berthiaume and Wallace, 2002). Primers were
designed based on sequence information in GenBank using OLIGO 5.0.
Pyruvate kinase (forward primer, caaggcccagagaagtatgatg; reverse primer,
gtggcagggaaggtctaggtag; 345 bp product) was used as a marker for nuclear
DNA, while cytochrome b (forward primer, atgaaacttcggctcactcct; reverseFig. 1. Exposure of HepG2 cells to hyperglycemia (30 mM) induce an increase on
the levels of PAI mRNA transcript. Cells were cultured in 5.5 mM or 30 mM
glucose for 48 h, 96 h and 7 days. PAI expression was quantified by real-time PCR
from a generated standard curve and normalized by calculating the ratio of PAI gene
copy number to 18S rRNA copy number. Bars represent themean±S.E.M. for three
different cell cultures. No statistically significant difference was observed between
HepG2 cells cultured in 5.5 mM and 30mMglucose for 48 h. Asterisk (⁎) indicates
statistical difference of the hyperglycemic condition (96 h and 7 days) when
compared with the respective normoglycemic (5.5 mM) control group ( pb0.05).primer, tgtatgggatggcggatagta; 377 bp product) was used as a marker for
mtDNA (IDT, Coralvill, IA). Real-time PCR reactions were prepared with
LightCycler® FastStart DNA Master SYBR Green 1 reagents according to kit
suggestions with 0.5 μM concentrations of each primer and 2 mM MgCl2, in a
LightCycler 1.5® (Roche Diagnostics, Indianapolis, IN). Samples were diluted
to 5 ng/μl and then 5 ng of sample was used to amplify the nuclear or the
mitochondrial gene products. Quantification of mtDNA was accomplished by
calculating the ratio of a mitochondrially encoded gene (cytochrome b) to a
nuclear encoded gene (pyruvate kinase) and expressing it as mtDNA copy
number per cell. To assess the specificity of the amplified PCR products, a
melting curve analysis was performed and reaction end products subjected to
gel electrophoresis. Copy numbers for each gene were calculated based on
standard curves. Standards were generated by PCR of DNA with specific
primers for each gene using Qiagen HotStartTaq Master Mix (Qiagen,
Valencia, CA). PCR was conducted in a Perkin-Elmer thermocycler. Agarose
gel electrophoresis was performed to verify products. Products were then
purified using a QIAquick PCR purification kit according to manufacturer's
instructions (Qiagen) and quantitated by measuring absorbance at 260 nm.
DNA copy number was calculated using the resulting concentration of DNA
and the following equation: MW=(product length×607.4)+157.9 (Ambion
Inc., Austin, TX).Fig. 3. High glucose-induced protein oxidation in HepG2 cells. Western blot
analysis of oxidative damage protein carbonylation was performed by using an
antibody against carbonyl groups as a marker for protein oxidative damage. The
loading and transfer of equal amounts of protein was confirmed by staining the
nitrocellulose membrane with Ponceau S (data not shown). The figure is repre-
sentative of results obtained with three different cultures exposed to hyper-
glycemia for 48 h and 7 days.
Fig. 4. Prolonged exposure to hyperglycemia (30 mM) induce a decrease in
mitochondrial oxygen consumption rates in digitonin-permeabilized HepG2
cells. Cells were cultured in 5.5 mM or 30 mM glucose for and 7 days. After
permeabilization with digitonin, oxygen consumption induced by glutamate/
malate (10 mM), ADP (1 mM), KCN (2 mM) was evaluated. Uncoupled
respiration or DNP-stimulated mitochondrial oxygen consumption (10 μM) was
also evaluated. Bars represent the means±S.E.M. for three different experiments.
No statistically significant difference was observed in KCN inhibition of oxygen
consumption between HepG2 cells cultured in 5.5 mM and 30 mM glucose.
Asterisks (⁎) indicate statistically significant difference of oxygen consumption
induced by glutamate/malate, ADP or DNP in HepG2 cells cultured in 30 mM
glucose when compared, respectively, with glutamate/malate, ADP or DNP
oxygen consumption in HepG2 cells cultured in 5.5 mM glucose ( pb0.05).
Fig. 6. Prolonged exposure of HepG2 cells to hyperglycemia (30 mM) induce a
decrease on mtDNA copy number per cell. Cells were cultured in 5.5 mM or
30 mM glucose for 48 h, 96 h and 7 days. mtDNAwas quantified by real-time
PCR by calculating the ratio of mitochondrial gene copy (cytochrome b) number
to nuclear gene (pyruvate kinase) copy number and expressing it as the mtDNA
copy number per cell. Copy numbers for each gene were calculated based on
standard curves. Bars represent themean±S.E.M. for three different cell cultures.
No statistically significant difference was observed in mtDNA copy number
between HepG2 cells cultured in 5.5 mM and 30 mM glucose for 48 and 96 h.
Asterisk (⁎) indicates statistical difference between cells cultured in 30 mM and
5.5 mM glucose for 7 days ( pb0.05).
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was extracted from cells using the RNeasy kit (Qiagen) and processed
according to manufacturer's suggestions. Reverse transcription PCR was
performed with the Omniscript RT Kit (Qiagen) using 1.0 μg of total RNA.
Each reaction was multiplexed, using the lower primer for both the
housekeeping gene, 18S rRNA, and the genes of interest to allow for
normalization. Primers were designed based on sequence information in
GenBank using OLIGO 5.0: TFAM (forward primer, catctgtcttggcaagttgtcc;
reverse primer, ccactccgccctataagcatc; 194 bp product), NRF-1 (forward
primer, gatggcactgtctcacttatcc; reverse primer, ctgatgcttgcgtcgtct; 193 bp
product), PAI-1 (forward primer, tagagaacctgggaatgaccga; reverse primer,
tgcgggctgagactatgaca; 171 bp product) and 18S (forward primer,
cgtattgcgccgctagaggt; reverse primer, ggtgaggtttcccgtgttgag; 327 bp product).
Real-time PCR was performed in a Lightcycler© using the SYBR Green
Master Mix Kit, as described in the previous section. Amplification of the 18S
and gene of interest were performed independently using the same reverse
transcription reaction.Fig. 5. Prolonged exposure of HepG2 cells to hyperglycemia (30 mM) induce a
decrease in MitoTracker Red staining. Fluorescence microscopy of HepG2 cells
cultured for 7 days in 5.5 mM (upper panel) or 30 mM glucose (lower panel),
stained with MitoTracker Red.Protein determination. Protein concentration was determined using the Bradford
protein assay with BSA as the protein standard (Bradford, 1976).
Statistical analysis. Data from three different experiments are presented as the
mean±S.E.M. Statistical significance between the different assays was made
using the two-way analysis of variance followed by the Newman–Keuls post-
test. p values b0.05 denoted the presence of a statistically significant difference.Fig. 7. Prolonged exposure of HepG2 cells to hyperglycemia (30 mM) induce a
decrease on TFAM mRNA transcript. Cells were cultured in 5.5 mM or 30 mM
glucose for 48 h, 96 h and 7 days. TFAM expression was quantified by real-time
PCR from a generated standard curve and normalized by calculating the ratio of
TFAM gene copy number to 18S rRNA copy number. Bars represent the mean±
S.E.M. for three different cell cultures. No statistically significant difference was
observed between HepG2 cells cultured in 5.5 mM and 30 mM glucose for 48
and 96 h. Asterisk (⁎) indicates statistical difference between cells cultured in
30 mM and 5.5 mM glucose for 7 days ( pb0.05).
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Hyperglycemia induces an increase in PAI-1 expression without
changes in cell viability
We examined cell viability in HepG2 cells exposed to
hyperglycemic conditions (30 mM glucose) for 48 h, 96 h and
7 days. No differences were observed in ethidium homodimer-1
and calcein-AM fluorescence when compared with cells
cultured in 5.5 mM glucose (data not shown). All cell cultures
were greater than 85% viable with all treatments and at all time
points. To confirm that extended exposure of HepG2 cells to
high glucose conditions was mimicking untreated diabetic
conditions, PAI-1 expression was evaluated. As shown in Fig. 1,
PAI-1 expression increased over time, reaching 60% increase at
7 days of exposure to hyperglycemia, indicating the possible
shunt of glucose into the hexosamine pathway, which plays a
modulatory role in PAI-1 expression (Brownlee, 2001; Gabriely
et al., 2002; Goldberg et al., 2002).
Hyperglycemia stimulates ROS generation that coincides with
accumulation of protein oxidation products
To determine the dynamics of ROS generation in HepG2
cells exposed to high glucose, we evaluated intracellular ROS
production with the fluorescent probe CM-H2DCF. Time
course experiments revealed that ROS increased at 48 h, with
an increase of 3.6 times in ROS generation after 7 days of
exposure to high glucose as compared to control (Fig. 2).
Immunodetection of carbonyl groups revealed protein oxida-
tion at 48 h, reaching a maximum after 7 days of exposure toFig. 8. Effect of high glucose exposure (30 mM) on the levels of NRF-1 mRNA
transcript in HepG2 cells. Cells were cultured in 5.5 mM or 30 mM glucose for
48 h, 96 h and 7 days. NRF-1 expression was quantified by real-time PCR from a
generated standard curve and normalized by calculating the ratio of NRF-1 gene
copy number to 18S rRNA copy number. Bars represent the mean±S.E.M. for
three different cell cultures. No statistically significant difference was observed.high glucose consistent with the ROS increase during
hyperglycemia (Fig. 3). The increase in protein carbonyl
content in HepG2 cells exposed to hyperglycemia was further
confirmed by spectrophotometric assay. Protein carbonyl
content was 2.56±0.11 and 4.37±0.37 nmol/mg protein in
cells exposed to hyperglycemia for 48 h and 7 days,
respectively.
Hyperglycemia induces a decrease in mitochondrial respiratory
rates and in MitoTracker Red fluorescence
To elucidate whether increased ROS generation was a cause
or a consequence of mitochondrial respiratory capacity, we
measured oxygen consumption in HepG2 cells under normal
and hyperglycemic conditions. No differences were observed at
96 h (data not shown). Uncoupled respiration (oxygen
consumption induced by the protonophore DNP, which makes
mitochondrial inner membrane permeable to protons) was
inhibited by 40% in digitonin-permeabilized HepG2 cells
cultured for 7 days in 30 mM glucose (Fig. 4). Exposure to
high glucose for 7 days induced a decrease in MitoTracker Red
fluorescence (Fig. 5), suggesting a decrease in mitochondrial
membrane potential or a decrease in the number of mitochon-
drial structures.
Hyperglycemia induces a decrease in mitochondrial biogenesis
To address if the loss of respiratory efficiency was due to a
loss of mitochondrial transcripts, mRNA levels of TFAM, NRF-
1 and mtDNA copy number were quantified by real-time PCR.
Exposure to high glucose for 7 days induced a 25% decrease in
mtDNA copy number at 7 days (Fig. 6). Concomitantly and as
shown in Fig. 7, TFAM transcripts, a direct regulator of mtDNA
replication/transcription and a stimuli for the regulation of
mitochondrial biogenesis and function (Wu et al., 1999) were
decreased 16% upon 7 days in hyperglycemic conditions. No
statistically significant difference was observed for NRF-1
transcripts (Fig. 8).
Discussion
Our data demonstrate that long-term exposure of HepG2 cells
to high glucose conditions leads to loss of respiratory capacity
and decreased mitochondrial biogenesis, the two of which may
be causally related.
ROS production via the mitochondrial respiratory chain has
been shown to be the causal link between high glucose and the
main pathways responsible for hyperglycemic damage. The
prevailing hypothesis is that hyperglycemia-induced increase
in electron transfer donors (NADH and FADH2) increases
electron flux through the mitochondrial electron transport
chain. Consequently, there is an increase of the ATP/ADP ratio
and hyperpolarization of the mitochondrial membrane poten-
tial. This high electrochemical potential generated by the
proton gradient leads to partial inhibition of the electron
transport in complex III, resulting in an accumulation of
reduced quinone. In turn, this drives partial reduction of O2 to
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2000a,b; Brownlee, 2001). It is this accelerated reduction of
coenzyme Q and generation of ROS that is believed to be the
fundamental source for oxidative injury and mitochondrial
dysfunction that plays a critical role in diabetes-related
metabolic disorders and tissue histopathology. In this study,
we first confirmed that hyperglycemia-induced ROS over-
production is associated with the induction of factors
responsible for diabetic complications. Coincident with the
increase in ROS generation, there was an accumulation of
oxidized proteins and an increase in PAI-1 expression, most
significant at 7 days of exposure. During hyperglycemia,
because of the increased nutrient availability, much of the
excess glucose is shunted into the hexosamine pathway. The
end product of this pathway, UDP-N-acetylglucosamine, is the
substrate for the glycosylation of important intracellular
factors (McClain and Crook, 1996) including transcription
factors. Accordingly, the expression of many genes including
PAI-1 is increased, leading to the development of the
microvascular complications of diabetes (Gabriely et al.,
2002; Goldberg et al., 2002).
Disruption of mitochondrial respiratory function has been
implicated as a key factor in the development of diabetic com-
plications (Rolo and Palmeira, 2006). Furthermore, a large
number of studies implicates reduction of transcription factors
that lead to a balanced program of mitochondrial biogenesis has
a causative factor for insulin resistance and diabetes (Rolo and
Palmeira, 2006). Reduced expression of oxidative phosphory-
lation genes has been observed in type 2 diabetes (Mootha et al.,
2003), accompanied by decreased expression of PGC-1α in
prediabetic and diabetic muscle (Patti et al., 2003). Insulin
resistance is associated with decreased protein content of the
ATP synthase β subunit (Hojlund et al., 2003). High-fat diet,
which leads to insulin resistance due to increased concentrations
of free fatty acids, downregulates PGC-1α mRNA and genes
encoding proteins for complexes I, II, III, and IV (Sparks et al.,
2005).
The relationship between ROS and these alterations in
mitochondrial biogenesis is still unclear. Recently, it has been
shown that hyperglycemic conditions are responsible for an
increase in ROS production that is accompanied by increased
fission or decreased fusion to fragment mitochondria (Yu et al.,
2006), probably as a physiologic response to increased
metabolic substrate availability. Our data clearly show that a
decrease in mtDNA copy number occurs after prolonged
exposure to high glucose (7 days in culture). These data suggest
that the functional consequence of the alteration in mitochon-
drial biogenesis is a decrease in the cell respiratory capacity at
7 days in culture. Despite the increase in ROS, protein oxidation
and PAI-1 expression, cell viability upon exposure to
hyperglycemia was not different from control. TFAM is a key
nuclearly encoded transcription factor, which translocates to
mitochondria and activates mitochondrial transcription and
mtDNA replication (Kelly and Scarpulla, 2004). TFB1M and
TFB2M markedly enhance mtDNA transcription in the
presence of TFAM and mitochondrial RNA polymerase.
Previous studies have shown that in transgenic mice, over-expression of TFAM is sufficient to increase mtDNA copy
number (Ekstrand et al., 2004). Also, in vitro, TFAM
overexpression appears sufficient to induce mitochondrial
transcription, but not mtDNA replication (Maniura-Weber et
al., 2004). On the other hand, reduction of TFAM by RNA
interference in HeLa cells or gene deletion in the mouse reduces
mtDNA copy number (Ekstrand et al., 2004; Kanki et al., 2004).
Thus TFAM is necessary for mtDNA replication and mito-
chondrial biogenesis. Although, in the present study, we did not
evaluate any other factors responsible for mitochondrial
biogenesis, we correlate the decrease in mtDNA copy
number/cell with a decrease in TFAM after 7 days of exposure
to hyperglycemia. Associated to these changes, is impairment in
mitochondrial function and a decrease in MitoTracker Red
staining (indicating a decrease in mitochondrial mass and/or a
decrease in mitochondrial membrane potential) after 7 days of
exposure to hyperglycemia, with an early increase in ROS
generation, observed as early as 48 h of exposure to 30 mM
glucose. Our data indicate that chronic exposure to high glucose
is responsible for a progressive alteration in gene expression,
including a decrease in mitochondrial biogenesis. This further
impairs oxidative metabolism and increases ROS production,
establishing a vicious metabolic cycle that will lead to
irreversible tissue damage in diabetes.
In conclusion, our findings indicate that modulation of mito-
chondrial biogenesis can be a therapeutic target to prevent a
chronic disturbance of the metabolic status in diabetes.
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